Recommended Talks:

eAccess Meetings: 2016 Keystone Symposia on HIV Vaccines
Ending the HIV/AIDS Pandemic: Follow the Science
November 2016
Anthony Fauci, NIAID, NIH
eAccess Meetings: 2016 Keystone Symposia on HIV Vaccines
A broadly neutralizing antibody from an elite neutralizer targets a novel site at the gp120-gp41 interface
November 2016
Marit J van Gils, University of Amsterdam
eAccess Meetings: 2016 Keystone Symposia on HIV Vaccines
A novel conserved-region T-cell mosaic vaccine with very high global coverage of HIV-1 variants is recognized by protective responses in chronic untreated infection
November 2016
Tomas Hanke, University of Oxford
Nucleic Acid Delivery Devices for HIV Vaccines
Exploring mechanisms of microneedle vaccine delivery to skin
May 2015
Linda Klavinskis, Kings College London
HIV Envelope Protein Manufacturing
Production of HIV ENV protein for P5 Clinical Studies
June 2015
Fred Porter, GSK Vaccines

Innovative Uses of Technology in HIV Clinical Trials

Various stakeholders share past experiences of innovative uses of technologies and discuss what could be adopted in future HIV clinical trials. Go to the meeting website...

Search:

Search term(s):

Search for text in:

separate each search
term with a space

Multiple terms:

Conference Years:

Content Type: